TABLE 2 .
Strains and plasmids used in this study
| Strain or plasmid | Relevant genotype or phenotypea | Reference(s) |
|---|---|---|
| Strains | ||
| V. cholerae HC-36A1 | Clinical, non-O1/non-O139, Haiti (Tabarre) 2010 (Ap Cm Kn Sp Sm Su Tc Tm) | 4 |
| E. coli | ||
| MG1655 Rf | Rfr derivative of MG1655 (Rf) | 52 |
| CAG18439 | MG1655 lacZU118 lacI42::Tn10 (Tc) | 63 |
| β2163 | (F−) RP4-2-Tc::Mu dapA::(erm-pir) (Kn Em) | 43 |
| Plasmids | ||
| pVCR94ΔX3 | Knr derivative of IncA/C plasmid pVCR94 (Kn Su) | 21 |
| pacaDC3×FLAG | pAH56::acaDC3×FLAG (Kn) | 21 |
| psetDC3×FLAG | pAH56::setDC3×FLAG (Kn) | 21, 41 |
a
Ap, ampicillin; Cm, chloramphenicol; Em, erythromycin; Kn, kanamycin; Rf, rifampin; Sm, streptomycin; Sp, spectinomycin; Su, sulfamethoxazole; Tc, tetracycline; Tm, trimethoprim.